Methylphenidate Treatment Response Study of Genetic Polymorphism in Attention Deficit Hyperactivity Disorder(ADHD)

• Status: Unknown status
• Trial end date: 2010-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether norepinephrine gene polymorphism affect to treatment response in ADHD

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Seoul National University Hospital
• Collaborator: Korea Health Industry Development Institute
• Treatments: Methylphenidate

Criteria

Inclusion Criteria:

• diagnosis made by DSM-IV and K-SADS-PL

• IQ > 71

Exclusion Criteria:

• genetic disorder

• history of acquired brain injury

• seizure disorder

• other neurologic disorder

• mental disorder, pervasive developmental disorder

• obsessive-Compulsive disorder

• communication disorder

• learning disorder